Co-exposure to cannabinoids and nicotine increases senescence in prenatal human lung development. (Pediatric Research. July 10, 2026)
Adjunctive Psychosocial Interventions and Opioid Abstinence Among Patients Receiving Buprenorphine
A Randomized Clinical Trial (JAMA Network Open. July 8, 2026)
Leveraging Machine Learning to Advance Alcohol Research: Current Applications, Challenges, and Opportunities (Alcohol Rsearch Current Reviews. July 2, 2026)
Stigma toward individuals with cannabis use disorder across age groups: associations with familiarity and sociodemographic characteristics. (Harm Reduction Journal. July 1, 2026)
Integrating ASAM/AAAP Guidelines Into the Advancement of Evidence-Based Treatments for Stimulant Use Disorder (ATTC Messenger. June 30, 2026)
Hippocampal volume alterations in opioid use disorder: Evidence for posterior vulnerability and heterogeneity (Drug and Alcohol Dependence. June 23, 2026)
The impact of severe mental illness on treatment retention and all-cause mortality among people in opioid agonist treatment (Drug and Alcohol Dependence. June 23, 2026)
Healthy Starts: Postpartum OUD Care Transitions for Mother and Infant (SAMHSA. June 17, 2026)
Charting the decline of the fourth wave: US overdose deaths by race, ethnicity and substance involvement (Addiction. June 18, 2026)
Expanding Methadone Access Through Community Pharmacies: A Qualitative Study Exploring Opioid Treatment Program Staff Perceptions of Pharmacy-Based Medication Units (Substance Use and Addiction Journal. June 18, 2026)
Charting the decline of the fourth wave: US overdose deaths by race, ethnicity and substance involvement (Addiction. June 9, 2026)
Federal Cuts for Naloxone Funding: Costs and Concerns, Part 2: The True Costs of Federal Naloxone Cuts (Anesthesiology News. June 5, 2026)
Post-Traumatic Stress Disorder & Cannabis: An Epidemiologic and Genetic Narrative Review (Not peer-reviewed. June 4, 2026)
Reducing Buprenorphine Misinformation as a Strategy to Improve Adoption in Primary Care (Substance Use and Misuse. June 3,, 2026)
Antenatal Opioid Exposure and Cerebral Cortical Maturation in Newborns (JAMA Network Open. June 3, 2026)
Once-Weekly Semaglutide in Adults With Daily Cigarette Use (JAMA Network Open. June 2, 2026)
ASAM Guest Editorial – Using Human-in-the-Loop AI to Understand Stigma During the Deployment of Addiction Evidence-Based Practices in the HEALing Communities Study (ASAM. June 2, 2026)
Addressing Cannabis Use Disorder in Primary Care Settings (SAMHSA. May 26, 2026)
What sleep physicians need to know about cannabis use for sleep (Free pdf download. Journal of Clinical Sleep Medicine. May 26, 2026)
Best Practices for Hospital-Based Initiation of Medications for Opioid Use Disorder: A Consensus Statement (JAMA Network Open. May 24, 2026)
Addressing gender disparities in the efficacy of psychological interventions for behavioral addictions: protocol for a systematic review and individual patient data meta-analysis of randomized controlled trials (Addiction Science and Clinical Practice. May 23, 2026)
From disruption to empowerment: Young people’s narratives of substance use treatment trajectories (Drugs: Education, Prevention and Policy. May 20, 2028)
Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial (American Journal of Psychiatry. May 19, 2026)
Alcohol Misuse in Older Women: A Scoping Review of Correlates, Consequences, Treatment, and Prevention (Alcohol Research Current Reviews. May 18, 2026)
Fact Sheet: 2026 National Drug Control Strategy (White House. May 12, 2026)
Edible Cannabis and Pain, Sleep, and Mental Health Management in Older Adults (JAMA Network. May 12, 2026)
Upgrading Housing-First Interventions in the Age of Fentanyl (JAMA Network. May 12, 2026)
Brain reward function in people with moderate-to-severe cannabis use disorder who tried to cut down or quit: an fMRI study (Free download . Nature. May 6, 2026)
Cascade of Care for Opioid Use Disorder Among Medicaid Beneficiaries (JAMA Network Open. May 6, 2026)
A thematic analysis of caregiver engagement in adolescent substance use treatment (Addiction Science and Clinical Practice. May 6, 2026)
Methamphetamine Use Among Adult Patients Presenting With Acute Coronary Syndrome: A Single‐Center Retrospective Cohort Study (Journal of the American Heart Association. April 30, 2026)
Treatment for opioid use and outcomes in older adults: a systematic literature review (Drug and Alcohol Dependence. April 30, 2026)
Prenatal exposure to buprenorphine or methadone and adverse neurodevelopmental outcomes: population based cohort study (British Medical Journal. April 30, 2026)
Prevalence of cannabis use in psychosis-affected youth: Insights from an Ontario-based early intervention cohort (Ethnicity in Substance Abuse. April 25, 2026)
A lifeline on wheels: perspectives of stakeholder on the implementation and impact of a mobile medications for opioid use disorder unit (Addiction Science and Clinical Practice. April 25, 2026)
An international mega-analysis of psychedelic drug effects on brain circuit function (Nature Medicine. April 25, 2026)
A µ-opioid receptor superagonist analgesic with minimal adverse effects (Nature. April 25, 2026)
Machine learning-based computational validation of the Addictions Neuroclinical Assessment framework in relation to hazardous drinking (Journal of Psychiatry and Neuroscience. April 22, 2026)
Impact of social determinants on opioid use disorder treatment engagement after release from jail: a case note content analysis (Addiction Science and Clinical Practice. April 22, 2026)
The Relationship Between Alcohol-Related Content on Social Media and Alcohol Outcomes in Young Adults: A Scoping Review (Alcohol Current Reviews. April 21, 2026)
Joint Relations Among Cannabis, Sleep, and Affective Symptomatology: A Scoping Review (Current Addiction Reports. April 18, 2026)
The cannabidiol (CBD): Tetrahydrocanabinol (THC) concentration ratio is critical for neuroprotection and recovery following traumatic brain injury (Experimental Neurology (pre-publication proof). April 18, 2026)
Methadone Dose and Patient-Directed Discharge in Hospitalized Patients With Opioid Use Disorder (JAMA Network. April 15, 2026)
Transcriptional regulation of ventral hippocampus-nucleus accumbens circuit excitability drives cocaine seeking (Science Advances. April 15, 2026)
Prevalence of cannabis use in psychosis-affected youth: Insights from an Ontario-based early intervention cohort (Ethnicity in Substance Abuse. April 25, 2026)
A lifeline on wheels: perspectives of stakeholder on the implementation and impact of a mobile medications for opioid use disorder unit (Addiction Science and Clinical Practice. April 25, 2026)
An international mega-analysis of psychedelic drug effects on brain circuit function (Nature Medicine. April 25, 2026)
A µ-opioid receptor superagonist analgesic with minimal adverse effects (Nature. April 25, 2026)
Machine learning-based computational validation of the Addictions Neuroclinical Assessment framework in relation to hazardous drinking (Journal of Psychiatry and Neuroscience. April 22, 2026)
Impact of social determinants on opioid use disorder treatment engagement after release from jail: a case note content analysis (Addiction Science and Clinical Practice. April 22, 2026)
The Relationship Between Alcohol-Related Content on Social Media and Alcohol Outcomes in Young Adults: A Scoping Review (Alcohol Current Reviews. April 21, 2026)
Joint Relations Among Cannabis, Sleep, and Affective Symptomatology: A Scoping Review (Current Addiction Reports. April 18, 2026)
The cannabidiol (CBD): Tetrahydrocanabinol (THC) concentration ratio is critical for neuroprotection and recovery following traumatic brain injury (Experimental Neurology (pre-publication proof). April 18, 2026)
Methadone Dose and Patient-Directed Discharge in Hospitalized Patients With Opioid Use Disorder (JAMA Network. April 15, 2026)
Transcriptional regulation of ventral hippocampus-nucleus accumbens circuit excitability drives cocaine seeking (Science Advances. April 15, 2026)
Early onset of cannabis use and risk for opioid use disorder across two decades in the United States (Addictive Behaviors. April 15, 2026)
Mirtazapine for Methamphetamine Use Disorder (JAMA Psychiatry. April 13, 2026)
Challenging the 25-year-old ‘mature brain’ mythology: implications for the minimum legal age for non-medical cannabis use (American Journal of Drug and Alcohol Abuse. April 11, 2026)
Yoga for Opioid Withdrawal and Autonomic Regulation: A Randomized Clinical Trial (JAMA Psychiatry. April 8, 2026)
Cocaine-Induced Cardiomyopathy as a Rare Etiology of Severe Heart Failure in Young Adults: A Case Report (Cureus. April 8, 2026)
Treating Addiction (National Institutes of Health. April 8, 2026)
Do US Adults View Drug and Alcohol Addiction as a Health Condition? (Journal of Addiction Medicine. April 7, 2026)
Essentials for Treating Behavioral Health in Primary Care: A Guide for the Primary Care Provider (Springer Publishing. April 5, 2026)
From controversy to clinical evidence: the evolving role of cannabis in pain therapy (European Archives of Psychiatry and Clinical Neuroscience. April 5, 2026)
Nonconceptus Mechanisms of Prenatal Alcohol Exposure That Disrupt Embryo-Fetal Development: An Integrative View (Alcohol Research Current Views. April 2, 2026)
Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum A Randomized Clinical Trial. (JAMA Internal Medicine. March 31, 2026)
Decreasing criminal legal system referrals to cannabis treatment in the US: Adolescent trends by race and ethnicity between 2010-2022 (American Journal of Preventative Medicine. March 31, 2026)
A computational mechanism linking momentary craving and decision-making in alcohol drinkers and cannabis users (Nature Mental Health. March 26, 2026)
Severity of Polysubstance Use Among Young People Seeking Drug and Alcohol Treatment, and Social and Mental Health Correlates: An Observational Study (Substance Use and Misuse. March 26, 2026)
Integrated treatment approaches for co-occurring mental health and substance use disorders: findings from a survey of European healthcare providers. (Irish Journal of Psychological Medicine. March 26, 2026)
Alcohol Use and Its Associations With Frailty, Fractures, and Falls Among Older Adults With HIV (Alcohol Rearch Current Reviews. March 26, 2026)
MicroRNA-132/212 negatively modulates opioid reward by targeting dopamine transporter in the ventral tegmental area (Translational Psychiatry. March 25, 2026)
Brain Function Outcomes of Recent and Lifetime Cannabis Use (JAMA Network Open. March 15, 2026)
Ketamine Therapy for Chronic Pain Provides Added Benefits for Substance Misuse Therapy (SVOA Medical Research. March 14, 2026)
A Narrative Review of Alcohol Prevention Interventions Among Older Adults (Alcohol Research Current Reviews. March 12, 2026)
Public Opinion on Legalizing Psychedelics (RAND Corporation. March 11, 2026)
Does the total consumption model apply to cannabis use? (Addiction. March 10, 2026)
Spirituality and Harmful or Hazardous Alcohol and Other Drug Use: A Meta-Analysis of Longitudinal Studies (JAMA Psychiatry. March 10, 2026)
Addictive drug abuse and depression-a focus on epigenetics (Communications Psychology. March 8, 2026)
Distorted Cartoonish Images in the Environment: A Unique Visual Phenomenon in Hallucinogen Persisting Perception Disorder (American Journal of Psychiatry. March 7, 2026)
Electrographic cue-reactivity co-localizes with accumbens deep brain stimulation in a case of opioid use disorder (Nature Communications. March 6, 2026)
Tracking a Fast-Moving Crisis: Systematic Assessment of Medetomidine and Xylazine-Related Health Harms (Johns Hopkins Center for Mental Health and Addiction Policy. March 5, 2026)
Statewide trends in access to medications for opioid use disorder (moud) among adolescents with opioid use disorders in Indiana (Drug and Alcohol Dependence Reports. March 4, 2026)
Alcohol’s Effects on the Lung and Lung Disease (Alcohol Research Current Reviews. March 4, 2026)
Adolescent Cannabis Use and Risk of Psychotic, Bipolar, Depressive, and Anxiety Disorders (JAMA Health Forum. March 4, 2026)
Trends in Benzodiazepine Prescribing to Adults in the United States: Results From the Medical Expenditure Panel Survey (Journal of Clinical Psychiatry. March 2, 2026)
Causal pathways from social media use to adolescent cannabis use: An instrumental variable mediation analysis of behavioral problems (Journal of Substance Use and Addiction Treatment. March 1, 2026)
Drinking motives among patients with alcohol use disorder: a longitudinal study (Addiction Science and Clinical Practice. February 27, 2026)
Perspective on Using Artificial Intelligence in Alcohol Research and Treatment: Opportunities and Ethical Considerations (Alcohol Research Current Reviews. February 25, 2026)
Public Opinion on Legalizing Psychedelics (Rand Corporation. February 25, 2026. Abstract and free pdf download))
U.S. Psychedelic Use and Microdosing in 2025 (RAND Corporation. February 24, 2026)
Insights into Carfentanil Use/Exposure from a Large National Database of Clinical Urine Drug Test Results (National Drug Early Warning System. February 20, 2026)
Factors associated with reduced substance use and treatment completion among justice-involved pregnant women (Frontiers in Psychiatry. February 19, 2026)
Patient-Centered Podcasts: An Educational Innovation to Improve Attitudes Toward Patients with Opioid Use Disorder Among Internal Medicine Practitioners (Journal of General Internal Medicine. February 10, 2026)
Health, Costs, and Injection-Related Infections at a Hypothetical Overdose Prevention Center (JAMA Network Open. February 10, 2026)
Assessing the Initial Impact of X-Waiver Elimination on Buprenorphine Prescribing for Opioid Use Disorder. (Substance Use and Addiction Journal. February 10, 2026)
Tianeptine use disorder: a narrative review (Alcoholism and Drug Addiction. February 8, 2026)
Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks (British Journal of Clinical Pharmacology. February 8, 2026)
Cannabidiol as a treatment for cocaine use disorder: a scoping review (Archives of Pharmacology. February 7, 2026)
Predicting substance use behaviors with machine learning using small sets of judgment and contextual variables (Mental Health Research. February 6, 2026)
Increase in Fatal Overdoses Linked to Novel Synthetic Opioid N-Propionitrile Chlorphine (Cychlorphine). (The Center for Forensic Science, Research and Education. February 4, 2026)
Standardizing Opioid Treatment Program Performance in the Era of Medicaid Reform (JAMA Network. February 4, 2026)
Medication Availability for Alcohol Use Disorder in Substance Use Disorder Treatment Facilities (JAMA Network Open. February 3, 2026)
As US Overdose Deaths Drop, Researchers Search for Explanations (JAMA Network Open. January 31, 2026)
Stimulant Use and Related Harms in Canada: Recent Trends (Canadian Centre on Substance Use and Addiction. January 31, 2026)
Extended-Release vs Sublingual Buprenorphine for Adolescent Opioid Use Disorder (ERA) (National Institute on Drug Abuse. January 28, 2026)
Public Views About Opioid Overdose and People With Opioid Use Disorder (JAMA Network Open. January 27, 2026)
A Heartbreaking Face of the Stimulant Crisis: The Cardiac Toll of Stimulant Use (American society of Addiction Medicine. January 27, 2026)
Effects of physical exercise interventions on multidimensional health outcomes in patients with substance use disorders: a network meta-analysis (Frontiers in Psychiatry. January 23, 2026)
The impact of internet addiction on non-suicidal self-injury among adolescents: a moderated chain mediation model (Frontiers in Psychology. January 23, 2026)
The addicted brain: How processed foods hijack reward pathways (Pharmacologic Research. January 21, 2026)
Yoga for Opioid Withdrawal and Autonomic Regulation: A Randomized Clinical Trial (JAMA Psychiatry. January 21, 2026)
Estimating thresholds for risk of cannabis use disorder using standard delta-9-tetrahydrocannabinol (THC) units (Addiction. January 21, 2026)
Trends in US Methamphetamine-related Mortality by Census Division, 2005–2023 (Addiction Medicine. January 20, 2026)
Are Americans sobering up? New trends in alcohol consumption in the United States (Addiction. January 20, 2026
Emergency Department–Initiated Buprenorphine for Opioid Use Disorder: A Systematic Review of Treatment Engagement and Emergency Care Utilization (Cureus Journal of Emegency Medicine. January 20, 2026)
Late-Onset Alcohol Abuse as a Presenting Symptom of Neurodegenerative Diseases (Abstact only. Journal of Alzheimer's Disease. January 20, 2026)
Influence of Gaming Addiction on Psychosocial Well-Being (Cureus Psychiatry. January 15, 2026)
US drug policy does not align with experts’ rankings of drug harms: a multi-criteria decision analysis (Abstact Only. Harm Reduction Journal. January 13, 2026)
US counties with the highest rates of EMS encounters for nonfatal buprenorphine-related overdoses per 10,000 population: January 1, 2023 - December 31, 2025 (National Drug Early Warning System. January 9, 2026)
New Study Reveals High Rates of Addiction Among Patients with Psoriasis and Other Conditions (Dermatology Times. January 6, 2026)
Barriers to Buprenorphine Initiation in Patients Using Fentanyl (JAMA Open Network. January 6, 2026)
DEA CY 2024 Methamphetamine Report (DEA, January 5, 2026)
Fentanyl’s Deadly Footprint: A New Framework for Predicting Overdose Hotspots (Cureus. January 6, 2026)
Rapid antidepressant potential of nitrous oxide: current state and major questions (Molecular Psychiatry. December 29, 2025)
Cannabis Use Disorder Emergency Department Visits and Hospitalizations and 5-Year Mortality (JAMA Network Open. December 23, 2025)
Will blockbuster obesity drugs revolutionize addiction treatment? (Nature. December 18, 2025)
Expedited referrals from community health center to opioid treatment program: innovative approaches to improving access to methadone treatment for patients who use opioids and experience homelessness (Addiction Science and Clinical Practice. December 17, 2025)
Opioid overdose associated with concomitant use of hydrocodone and selective serotonin reuptake inhibitors (BMC Medicine. December 17, 2025)
Breaking barriers: evaluating access models for harm reduction vending machines (international Journal of Drug Policy. December 17, 2025)
Productivity Losses From Substance Use Disorder in the U.S. in 2023 (American Journal of Preventive Medicine. December 17, 2025)
The NOD (Naltrexone for Overdose Prevention) study protocol: a pilot randomized controlled trial of intramuscular naltrexone for opioid overdose prevention among people who use stimulants living with or at risk for HIV (Addiction Science and Clinical Practice. December 16, 2025)
Innovations in recovery science: pathways, policies, and platforms that promote thriving after addiction (Frontiers in Public Health. December 12, 2025)
Neurodevelopmental outcomes following prenatal cannabidiol exposure in male and female Sprague Dawley rat offspring (Neuroscience. December 11, 2025)
Reducing drug-related harm by triggering proactive outreach (BMJ Open Quality. December 10, 2025)
Tracking functional recovery in a community-based substance use disorder program: a five-year descriptive evaluation using the brief addiction monitor (Addiction Science and Clinical Practice. December 9, 2025)
ASAM Editorial — Medicaid Unwinding May Have Substantially Disrupted Buprenorphine Treatment (ASAM. December 9, 2025)
The Nexus of Substance Use Disorders and Sexually Transmitted Illnesses: A Call for Syndemic Solutions (Addiction Messenger. December 8, 2025)
Psilocybin triggers an activity-dependent rewiring of large-scale cortical networks (Cell. December 8, 2025)
Acute Effects of Cannabis on Alcohol Craving and Consumption: A Randomized Controlled Crossover Trial (American Journal of Psychiatry. December 5, 2025)
New Onset Psychosis Following Cannabis Discontinuation: A Case Report (Psychiatry Research Case Reports. December 5, 2025)
Negative Affect Circuit Subtypes and Neural, Behavioral, and Affective Responses to MDMA:
A Randomized Clinical Trial (JAMA Network Open. December 3, 2025)
A meta-analytic analysis of the acute effects of MDMA on empathy and emotion recognition in humans (Nature. December 3, 2025)
Safety Considerations for Patients Using Cannabis (Mental Health Clinician. December 3, 2025)
ASAM Editorial — Contingency Management Saves Lives: From Evidence to Action (American Society of Addiction Medicine. December 2, 2025)
Prelimbic cortex to ventral tegmental area projection regulates early social isolation stress-potentiated heroin seeking in mice (Nature Communications. December 1, 2025)
Understanding overdose risk and response in permanent supportive housing: results of focus groups with tenants, staff, and leaders (Addiction Science and Clinical Practice. November 29, 2025)
Efficacy of cognitive behavioral therapy for stimulant use disorders: a systematic review and meta-analysis (Frontiers in Psychiatry. November 28, 2025)
State laws banning prior authorization for medications for opioid use disorder increased substantially, 2015–23 (Health Affairs. November 25, 2025)
Selective activation of cannabinoid receptors by cannabis terpenes (Biochemical Pharmacology. November 22, 2025)
Tolerance to Stimulant Medications in the Treatment of Children With ADHD (Psychiatric Times. November 22, 2025)
Acute Effects of Cannabis on Alcohol Craving and Consumption: A Randomized Controlled Crossover Trial (American Journal of Psychiatry. November 20, 2025)
Health risks of cocaine adulteration: local anesthetics as modulators of monoamine and organic cation transporters (Frontiers in Pharmacology. November 19, 2025)
Internet Searches for Lorazepam Following the Release of The White Lotus (JAMA Health Forum. January 19, 2025)
How to implement a naloxone supply approach in hospitals (The Pharmaceutical Journal. November 19, 2025)
Use of low-threshold naloxone boxes for opioid overdose prevention in a Midwestern US State: a public health program evaluation (Harm Reduction Journal. November 18, 2025)
Beyond opioids: cannabis and the changing landscape of cancer pain (Academia Oncology. November 18, 2025)
Systemic Inertia in Addiction Care: Institutional Hesitancy and Ethical Barriers to Buprenorphine Initiation (Cureus. November 18, 2025)
Editorial: Are we too high on medicinal cannabis in child psychiatry? Examining the evidence in Tourette Syndrome (Journal of Child Psychiatry and Psychology. November 14, 2025)
Cocaine seeking and consumption are oppositely regulated by mesolimbic dopamine in male rats (Nature. November 13, 2025)
Cannabinology in Dentistry: Therapeutic Applications and Future Directions (International Journal of Oral and Dental Health. November 12, 2025)
How Do We Increase Treatment for Alcohol Use Disorder in Primary Care? It Takes a Team (Journal of General Internal Medicine. November 12, 2025)
GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer (Journal of the Endocrine Society. November 11, 2025)
Shattering the STIGMA: Talking openly about MAT in 12-step recovery programs (Journal of Substance Use and Addiction Treatment. November 11, 2025)
Simplified rapid low-dose buprenorphine induction method for individuals using fentanyl: a case series (Addiction Science and Clinical Practice. November 7, 2025)
Serial Ketamine Infusions as Adjunctive Therapy to Inpatient Care for Depression (JAMA Psychiatry. November 6, 2025)
States With Substantial Increases in Buprenorphine Uptake Did So with Increased Medicaid Prescribing (Health Affairs. November 4, 2025)
Medicinal cannabinoid use and the risk of developing psychoses and suicidality (Current Opinion in Toxicology. November 4, 2025)
Health Service Use Among Young Adults With a History of Adolescent Cannabis Use (JAMA Open Network. November 1, 2025)
Linkage to substance use disorder treatment through syringe services programs and the criminal legal system: A Cross-Sectional Study (American Journal of Preventative Medicine. October 29, 2025)
Inpatient addiction care is associated with increased vaccinations, medication for opioid use disorder and naloxone prescribing among patients with infective endocarditis in a rural state (Addiction Science and Clinical Practice. October 29, 2025)
The association of opioid use disorder with cerebral aneurysm rupture (Drug and Alcohol Dependence. October 29, 2025)
Characteristics and risk factors of opioid poisoning in opioid-dependent individuals using their primary opioid of dependence: a registry-based study (International Journal of Emergency Medicine. October 28, 2025)
A protocol for a randomized comparison of extended-release versus sublingual buprenorphine among pre-trial detainees in jail (Addiction Science and Clinical Practice. October 28, 2025)
Serial Ketamine Infusions as Adjunctive Therapy to Inpatient Care for Depression (JAMA Psychiatry. October 27, 2025)
Gas station heroin- tianeptine and its impact: a systematic review and exploratory analysis (BMC Public Health. October 26, 2025)
Determining the detection of 216 fentanyl analogs and synthetic opioids and predicting epitopes using four commercial immunoassays (Clinical Biochemistry. October 26, 2025)
Measuring cannabis use and cannabis-related consequences among college students who engage in simultaneous alcohol and cannabis use: Associations by type of cannabis product and mode of use on weekend days with cannabis (Abstract only. Addictive Behaviors. October 26, 2025)
Sexual diversity, adolescent mental health, and adult cannabis use: Longitudinal associations through cannabis use motives (Addictive Behaviors. October 25, 2025)
Sleep quality and duration following the use and co-use of alcohol and cannabis in the daily life of community adults (Drug and Alcohol Dependence. October 25, 2025)
Advancing pre-exposure prophylaxis (PrEP) implementation for people who use drugs: an introduction to and lessons from the special series (Addiction Science and Clinical Practice. October 25, 2025).
The effects of tetrahydrocannabinol and cannabidiol on sleep in cancer patients (Clinical and Translational Oncology. October 24, 2025)
Craving Prediction From fMRI Drug Cue Reactivity in Methamphetamine Use Disorder: A Parsimonious Neurobiological Model (Brain and Behavior. October 23, 2025)
Methamphetamine-Associated Heart Failure: A Patient-Centered Approach to Care (JACC Case Reports. October 22, 2025)
Editorial – Gambling Disorder in the Age of Mobile Sports Betting (ASAM. October 22, 2025)
Cannabis and Alcohol Use to Initiate Sleep Among Young Adults (JAMA Pediatrics. October 22, 2025)
Standardized ketamine infusion protocol for chronic refractory pain (Regional Anesthesia and Pain Medicine. October 21, 2025)
Low-frequency electroacupuncture attenuates methamphetamine-induced depressive-like behaviors and cognitive impairment via modulating neuroinflammation (Frontiers in Neurobiology, October 20, 2025)
Single Treatment With MM120 (Lysergide) in Generalized Anxiety Disorder (Abstract only. JAMA Network. October 20, 2025)
JRW Behavioral Health Services